Case Report: Term Pregnancy (36 Weeks) With Premature Rupture of Membranes and Untreated Schizophrenia Prior to Labor Onset

Authors

  • Haikal Nirfandi Medical Faculty Lampung University
  • Ratna Dewi Puspita Sari
  • Reynhard Theodorus Saragih

DOI:

https://doi.org/10.53089/medula.v15i2.1621

Keywords:

Antipsychotics, cesarean section, perinatal mental disorders, pregnancy, schizophrenia

Abstract

Perinatal mental disorders, including schizophrenia, increase the risk of complications during pregnancy, labor, and neonatal health. Schizophrenia in pregnant women can lead to premature rupture of membranes, preterm labor, and fetal distress. The use of antipsychotics during pregnancy is also associated with an increased risk of obstetric and metabolic side effects. This case report presents a 38-year-old pregnant woman, G5P4A0, at 36 weeks of gestation, with a seven-year history of untreated schizophrenia, who presented with premature rupture of membranes. Examination revealed stable maternal condition, although fetal distress was suspected. The patient was treated with intravenous fluids, antibiotics, tocolytics, and antipsychotics (haloperidol, CPZ, risperidone), and subsequently underwent cesarean section due to fetal distress. Women with schizophrenia are at higher risk of premature rupture of membranes, fetal distress, and preterm delivery. Antipsychotic use during pregnancy also increases the risk of complications such as gestational diabetes and metabolic disorders. The management of pregnant women with mental disorders requires a multidisciplinary approach involving psychiatrists, obstetricians, and neonatologists to minimize risks to both mother and fetus. Close monitoring of maternal medical conditions, medication dosages, and fetal growth is essential to optimize care, and decisions regarding the mode of delivery should consider both psychiatric and obstetric conditions.

Author Biographies

Haikal Nirfandi, Medical Faculty Lampung University

 

 

Ratna Dewi Puspita Sari

 

 

Reynhard Theodorus Saragih

 

 

References

Edinoff AN, Sathivadivel N, McNeil SE, Ly AI, Kweon J, Kelkar N, et al. Antipsychotic use in pregnancy: patient mental health challenges, teratogenicity, pregnancy complications, and postnatal risks. Neurol Int. 2022;14:62–74.

Etchecopar-Etchart D, Mignon R, Boyer L, Fond G. Schizophrenia pregnancies should be given greater health priority in the global health agenda: results from a large-scale meta-analysis of 43,611 deliveries of women with schizophrenia and 40,948,272 controls. Mol Psychiatry. 2022;27(8):3294–305.

Jablensky AV, Morgan V, Zubrick SR, Bower C, Yellachich LA. Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders [Internet]. Am J Psychiatry. 2005;162. Available from: http://ajp.psychiatryonline.org

Newport DJ, Calamaras MR, DeVane BC, Donovan JP, Beach AJ, Winn SB, et al. Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes. Am J Psychiatry. 2007;164.

Paschetta E, Berrisford G, Coccia F, Whitmore J, Wood AG, Pretlove S, et al. Perinatal psychiatric disorders: an overview. Am J Obstet Gynecol. 2014;210.

Huybrechts KF, Hernández-Díaz S, Patorno E, Desai RJ, Mogun H, Dejene SZ, et al. Antipsychotic use in pregnancy and the risk for congenital malformations. JAMA Psychiatry. 2016;73(9):938–46.

Petersen I, McCrea RL, Sammon CJ, Osborn DPJ, Evans SJ, Cowen PJ, et al. Risks and benefits of psychotropic medication in pregnancy: cohort studies based on UK electronic primary care health records. Health Technol Assess. 2016;20(23):1–208.

Gentile S. Antipsychotic therapy during early and late pregnancy: a systematic review. Schizophr Bull. 2010;36:518–44.

Habermann F, Fritzsche J, Fuhlbrück F, Wacker E, Allignol A, Weber-Schoendorfer C, et al. Atypical antipsychotic drugs and pregnancy outcome: a prospective cohort study. J Clin Psychopharmacol. 2013;33(4):453–62.

Brailon A, Bewley S. Pregnancy, delivery and neonatal complications in women with schizophrenia: a national population-based cohort study. Lancet Reg Health Eur. 2021;10.

Vickery PB. Concepts for selection and utilization of psychiatric medications in pregnancy. Ment Health Clin. 2023;13(6):255–67.

Ifteni P, Moga MAM, Burtea V, Correll CU. Schizophrenia relapse after stopping olanzapine treatment during pregnancy: a case report. Ther Clin Risk Manag. 2014;10:901.

Indarti J, Ocviyanti D, Umami EA. Management of schizophrenia in pregnancy: a case report. Jurnal Obstetri dan Ginekologi Indonesia. 2019.

Fatimah S, Fatmasaanti AU, Batari AK, Watampone T. Analisis faktor yang berhubungan dengan jenis persalinan pada ibu hamil. Jurnal Kebidanan. 2020;6.

Published

2025-07-01

How to Cite

Nirfandi, H. ., Sari, R. D. P., & Saragih, R. T. (2025). Case Report: Term Pregnancy (36 Weeks) With Premature Rupture of Membranes and Untreated Schizophrenia Prior to Labor Onset. Medical Profession Journal of Lampung, 15(2), 337-341. https://doi.org/10.53089/medula.v15i2.1621

Issue

Section

Artikel

Most read articles by the same author(s)

1 2 > >>